August 11, 2022 · STOCK Act disclosure
Representative Josh Gottheimer (Democrat-NJ) bought BioCryst Pharmaceuticals, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on August 11, 2022 and was disclosed on September 16, 2022 (owner: Joint). Members of Congress must report such transactions within 45 days under the STOCK Act.